Evidence map›Paper›PMID 30666640›Full record

ArticleJournal of cellular physiology2019

Construction of microRNA-messenger networks for human osteosarcoma.

Guifu Ma, Chao Zhang, Wenyuan Luo, Jia-Li Zhao, Xuebin Wang, Yaowen Qian

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Translational pediatrics · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Guifu MaDepartment of Orthopedics, Gansu Provincial Hospital, Lanzhou, China.
Chao ZhangDepartment of Orthopedics, Gansu Provincial Hospital, Lanzhou, China.
Wenyuan LuoDepartment of Orthopedics, Gansu Provincial Hospital, Lanzhou, China.
Jia-Li ZhaoDepartment of Orthopaedics, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, Jiangsu, China.ORCID 0000-0003-2220-3952
Xuebin WangEmergency Department, Gansu Provincial Hospital, Lanzhou, China.
Yaowen QianDepartment of Orthopedics, Gansu Provincial Hospital, Lanzhou, China.
Gansu Provincial Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma is the most common bone tumor in children and young adults. Although the microRNAs (miRNA) expression analyses of osteosarcoma have been performed previously, the construction of miRNA-messenger RNA (mRNA) networks for osteosarcoma is needed. This study aimed to identify osteosarcoma-related miRNAs through analyzing the microarray datasets and to construct the regulatory network of miRNA-mRNA for human osteosarcoma. The datasets were extracted from the Gene Expression Omnibus and the differentially expressed miRNAs were screened through the limma package in Bioconductor. Genes targeted by the differentially expressed miRNAs were screened out by using the Miranda, MirTarget2, PicTar, PITA, and TargetScan databases. The predicted target genes were further analyzed by Gene Ontology and pathway enrichment analysis and a regulatory network of differentially expressed miRNAs and their target osteosarcoma-associated genes was constructed. A total of 36 downregulated miRNAs and 182 upregulated miRNAs were identified in osteosarcoma samples compared with normal samples and 397 target genes for upregulated miRNAs and 222 target genes for downregulated miRNAs were obtained. The enriched pathways for target genes of differentially expressed miRNAs included transcriptional misregulation in cancer, the AMPK signaling pathway, and MAPK signaling pathway. In the regulatory network, has-miR-199a-5p targeted the highest number of genes and nemo-like kinase (NLK) was targeted by five miRNAs (hsa-miR-140-5p, hsa-miR-107, hsa-miR-324-5p, hsa-miR-199a-5p, and hsa-miR-28-5p). The has-miR-324-5p targets NLK, TGFB2, and PPARG. These miRNAs and their target genes may serve as potential therapeutic targets of osteosarcoma.

Indexed as

Cell Line, TumorGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMAP Kinase Kinase 1MicroRNAsOsteosarcomaPPAR gammaProtein Serine-Threonine KinasesRNA, MessengerSignal TransductionTransforming Growth Factor beta2MAP Kinase Kinase 1MicroRNAsMIRN107 microRNA, humanMirn140 microRNA, humanmirn199 microRNA, humanMIRN28 microRNA, humanMIRN324 microRNA, humanNLK protein, humanPPAR gammaPPARG protein, humanProtein Serine-Threonine KinasesRNA, MessengerTGFB2 protein, humanTransforming Growth Factor beta2differentially expressed miRNAosteosarcomapathway enrichment analysisregulatory network

Identifiers

PMID30666640
PMCPMC13483061
OpenAlexW2913555828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.